RLPC-Bankers prepare almost $1bn of debt for LTS Lohmann sale
LONDON Oct 4 (Reuters) - Bankers are putting together about 700 million euros ($954 million) of debt financing to back a sale of German medical patch manufacturer LTS Lohmann, banking sources said on Friday.
LTS, in which Novartis owns a 43 percent stake, was put up for sale in July and is expected to fetch more than 1 billion euros.
First-round bids are expected to be submitted on Oct. 4, one of the sources said, with private equity firms EQT and Advent International among the potential buyers.
Novartis was not immediately available for comment.
Bankers are working on debt packages of about seven times the company's approximate 95 million euro earnings before interest, tax, depreciation and amortisation (EBITDA), the banking sources said.
A range of debt instruments are being considered, including senior leveraged loans and subordinated debt such as high-yield bonds or mezzanine financing, denominated in both euros and dollars, the sources added.
Bankers will be eager to do the deal given the lack of merger and acquisition activity this year. The deal, being handled by Morgan Stanley, is expected to be attractive to prospective buyers, given the sector's resilience during the euro zone crisis.
LTS makes about 200 million euros in annual sales from nicotine and other medical patches to treat conditions including Parkinson's Disease and Restless Legs Syndrome. ($1 = 0.7340 euros) (Editing by David Goodman)
- Insight: How U.S. spying cost Boeing multibillion-dollar jet contract
- Exclusive: Secret contract tied NSA and security industry pioneer |
- With Fed out of the way, what's next on Wall Street?
- U.S. aircraft hit by gunfire in South Sudan as conflict worsens |
- Seagram chairman, WJC head Edgar Bronfman dead at 84